Due to COVID-19 restrictions, a selection of on-campus papers will be made available via distance and online learning for eligible students.
Find out which papers are available and how to apply on our COVID-19 website
Drug, disease and patient factors involved in the pharmacotherapeutic management of musculoskeletal and reproduction disorders and oncology.
|Paper title||Quality Use of Medicines B|
|Teaching period||First Semester|
|Domestic Tuition Fees (NZD)||$2,612.16|
|International Tuition Fees (NZD)||$12,632.96|
- PHCY 471
- Limited to
- Teaching staff
- Dr Shyamal Das
- Textbooks are not required for this paper.
- Graduate Attributes Emphasised
- Communication, Critical thinking, Self-motivation.
View more information about Otago's graduate attributes.
- Learning Outcomes
- The aim of this paper is for students to be able to formulate the components of a
care plan. Pharmaceutical care plans are individualised/patient-focused treatment
strategies developed by clinical pharmacists. A care plan involves the following processes:
- Assessment of the patient
- Formulation of a treatment option
- Enacting this treatment option
- Monitoring the patient's outcomes
- Reflection on outcomes
- Return to "assessment of the patient" and continue the cycle